Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$209.01 - $232.56 $4,180 - $4,651
-20 Reduced 0.65%
3,071 $670,000
Q4 2023

Feb 01, 2024

BUY
$197.69 - $227.29 $103,787 - $119,327
525 Added 20.46%
3,091 $702,000
Q3 2023

Oct 11, 2023

BUY
$201.05 - $221.7 $261,365 - $288,210
1,300 Added 102.69%
2,566 $515,000
Q2 2023

Aug 04, 2023

BUY
$211.93 - $241.33 $268,303 - $305,523
1,266 New
1,266 $305,000
Q3 2018

Nov 14, 2018

SELL
$167.67 - $188.27 $33,534 - $37,654
-200 Closed
0 $0
Q2 2018

Aug 02, 2018

SELL
$160.33 - $189.41 $11,704 - $13,826
-73 Reduced 26.74%
200 $36,000
Q1 2018

May 14, 2018

BUY
$161.53 - $178.11 $44,097 - $48,624
273 New
273 $44,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Adviser Investments LLC Portfolio

Follow Adviser Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adviser Investments LLC with notifications on news.